Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers

References

• Sweetman SC. Martindale: the complete drug reference. 37th ed. London: The Pharmaceutical Press; 2011. E. version
   Google Scholar
• Moffat AC, Osselton MD, Widdop B. Clarke’s analysis of drugs and poisons. 4th ed. London: The Pharmaceutical Press; 2011. E. version
   Google Scholar
• Lappin G, Shishikura Y, Jochemsen R, et al. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability. Eur J Pharm Sci 2010;40:125–131
   PubMed Web of Science ®Google Scholar
• Gupta A, Mishra AK, Gupta V, et al. Recent trends of fast dissolving tablet – an overview of formulation technology. Int J Pharm Bio Arch 2010;1:1–10
   Google Scholar
• Madgulkar AR, Bhalekar MR, Patel KG, et al. Comparative evaluation of taste masking methods for fexofenadine HCl. Pharm Rev 2007;October–November:176–187
   Google Scholar
• Jain SP, Mehta DC, Shah SP, et al. Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid. AAPS PharmSciTech 2010;11:917–923
   PubMed Web of Science ®Google Scholar
• Swapnil UW, Prashant S, Ashwini NY. Formulation of Oro-dispersible tablets containing drug-resin complex. Der Pharm Lett 2010;2:212–216
   Google Scholar
• Van Spronsen FJ, Hoeksma M, Reijngoud DJ. Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 2009;32:46–51
   PubMed Web of Science ®Google Scholar
• Simon KR, Dos Santos RM, Scaini G, et al. DNA damage induced by phenylalanine and its analogue p-chlorophenylalanine in blood and brain of rats subjected to a model of hyperphenylalaninemia. Biochem Cell Biol 2013;91:319–324
   PubMedGoogle Scholar
• Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech 2006;7:E1–F9
   PubMedGoogle Scholar
• Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech 2006;7:E87–E92
   PubMed Web of Science ®Google Scholar
• Ibrahim HK, El-Setouhy DA. Valsartan orodispersible tablets: formulation, in vitro/in vivo characterization. AAPS PharmSciTech 2010;11:189–196
   PubMed Web of Science ®Google Scholar
• Aboelwafa AA, Fahmy RH. A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design. Pharm Dev Technol 2012;17:1–14
   PubMed Web of Science ®Google Scholar
• Abed KK, Hussein AA, Ghareeb MM, Abdulrasool AA. Formulation and optimization of orodispersible tablets of diazepam. AAPS PharmSciTech 2010;11:356–361
   PubMed Web of Science ®Google Scholar
• Bora D, Borude P, Bhise K. Taste masking by spray-drying technique. AAPS PharmSciTech 2008;9:1159–1164
   PubMed Web of Science ®Google Scholar
• Kim EH, Choi HK. Preparation of various solid–lipid beads for drug delivery of enrofloxacin. Drug Deliv 2004;11:365–370
   PubMed Web of Science ®Google Scholar
• Shah PP, Mashru RC. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique. AAPS PharmSciTech 2008;9:494–500
   PubMed Web of Science ®Google Scholar
• European Pharmacopeial Commission. European Pharmacopeia. 7th Edition, Strasbourg: Council of Europe: European Directorate for the Quality of Medicines and Healthcare, 2011. E. version
   Google Scholar
• Mou-ying FL, Saul B, Linda W, et al. A polymeric carrier system for taste masking of macrolide antibiotics. Pharm Res 1991;8:706–712
   PubMedGoogle Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits. AAPS PharmSciTech 2013;14:782–793
   PubMed Web of Science ®Google Scholar
• Zhong L, Zhu X, Luo X, Su W. Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation. AAPS PharmSciTech 2013;14:541–550
   PubMed Web of Science ®Google Scholar
• Gohel M, Patel M, Amin A, et al. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech 2004;5:10–15
   Web of Science ®Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–49
   PubMed Web of Science ®Google Scholar
• Moore J, Flanner H. Mathematical comparison of dissolution profiles. Pharm Tech 1996;20:64–74
   Google Scholar
• Miura M, Uno T, Tateishi T, Suzuki T. Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography. J Pharm Biomed Anal 2007;43:741–745
   PubMed Web of Science ®Google Scholar
• US DHHS, FDA and CDER. Guidance for industry: bioanalytical method validation. Rockville (MD): US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 2001
   Google Scholar
• Hubert Ph, Chiap P, Crommen J, et al. The SFSTP guide on the validation of chromatographic methods for drug bioanalysis: from the Washington Conference to the laboratory. Anal Chim Acta 1999;391:135–148
   Web of Science ®Google Scholar
• Guo D, Zou J, Zhu Y, et al. Measurement of fexofenadine concentration in micro-sample human plasma by a rapid and sensitive LC–MS/MS employing protein precipitation: application to a clinical pharmacokinetic study. Biomed Chromatogr 2010;24:335–341
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nagai T, Shimura T, Yasoshima Y. Roles of chemical mediators in the taste system. Jpn J Pharmacol 1998;76:325–348
   PubMedGoogle Scholar
• Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 7th ed. London: Pharmaceutical Press and American Pharmacists Association; 2012. E. Version
   Google Scholar
• Passerini N, Perissutti B, Albertini B, et al. Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J Control Release 2003;88:263–275
   PubMed Web of Science ®Google Scholar
• Ghorab DM, Amin MM, Khowessah OM, Tadros MI. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats. Drug Del 2011;18:523–535
   PubMed Web of Science ®Google Scholar
• Zhao N, Augsburger LL. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS PharmSciTech 2005;6:E120–E126
   PubMed Web of Science ®Google Scholar
• Venkata RRS, Sathyanarayana D, Manavalan R, Sreekanth J. Formulation development and process comparison of different compressed oral disintegrating tablets. Der Pharm Lett 2010;2:176–186
   Google Scholar
• Venkata RRS, Sathyanarayana D, Manavalan R, Sreekanth J. Comparison of lyophilization and compression technique of risperidone oral disintegrating tablets. Der Pharm Chem 2010;2:172–184
   Google Scholar
• Wells JI, Rubinstein MH. Pharmaceutical technology: tableting technology. Vol. 2: Compression. 1st ed. England: Ellis Horwood; 1993:65–80
   Google Scholar
• Anraku M, Arahira M, Mady FM, et al. Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans. Pharmazie 2010;65:461–466
   PubMed Web of Science ®Google Scholar
• Ibrahim MA, Al-Anazi FK. Enhancement of the dissolution of albendazole from pellets using MTR technique. Saudi Pharm J 2013;21:215–223
   PubMed Web of Science ®Google Scholar
• Abdul-Rasool BK, Fahmy SA, Abdul-Galeel OW. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations. Pak J Pharm Sci 2012;25:815–822
   PubMedGoogle Scholar
• Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm 2009;73:162–171
   PubMed Web of Science ®Google Scholar